Dr. Sabine s Coppieters, MD
Claim this profileInvestigator site 3590005
Studies Myasthenia Gravis
Studies Muscle Weakness
25 reported clinical trials
13 drugs studied
Affiliated Hospitals
Clinical Trials Sabine s Coppieters, MD is currently running
Efgartigimod IV
for Myasthenia Gravis
The purpose of this trial is to investigate the PK, PD, safety, and activity of efgartigimod IV in children and adolescents aged from 2 to less than 18 years of age with gMG. Trial details include: * The maximum trial duration for each individual participant will be approximately 28 weeks * The treatment duration will be 8 weeks for the dose-confirmatory part (Part A) and 18 weeks for the treatment response-confirmatory part (Part B)
Recruiting1 award Phase 2 & 39 criteria
Efgartigimod
for Myasthenia Gravis
The primary purpose of this study is to measure the efficacy and safety of efgartigimod intravenously (IV) compared to placebo in participants with Acetylcholine Receptor Binding Antibody (AChR-Ab) seronegative Generalized Myasthenia Gravis (gMG). Other objectives are to assess long-term efficacy, safety, and tolerability of efgartigimod. Study will consist of: * Screening * Part A: participants will be randomized to receive either efgartigimod IV or placebo * Part B: participants completing part A will receive open-label efgartigimod IV
Recruiting1 award Phase 3
More about Sabine s Coppieters, MD
Clinical Trial Related3 years of experience running clinical trials · Led 25 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Sabine s Coppieters, MD has experience with
- Efgartigimod PH20 SC
- Efgartigimod PH20 SC
- Placebo
- Efgartigimod
- Efgartigimod IV
- Prednisone
Breakdown of trials Sabine s Coppieters, MD has run
Myasthenia Gravis
Muscle Weakness
Amyloidosis
- A Worldwide Pregnancy Safety Study to Assess Maternal, Fetal, and Infant Outcomes Following Exposure to Efgartigimod During Pregnancy And/or Breastfeeding.
- Efgartigimod SC for CIDP
- A Study to Assess the Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP, an Autoimmune Disorder That Affects the Peripheral Nerves)
Chronic Inflammatory Demyelinating Polyradiculoneuropathy
- A Worldwide Pregnancy Safety Study to Assess Maternal, Fetal, and Infant Outcomes Following Exposure to Efgartigimod During Pregnancy And/or Breastfeeding.
- Efgartigimod SC for CIDP
- A Study to Assess the Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP, an Autoimmune Disorder That Affects the Peripheral Nerves)
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Sabine s Coppieters, MD specialize in?
Sabine s Coppieters, MD focuses on Myasthenia Gravis and Muscle Weakness. In particular, much of their work with Myasthenia Gravis has involved acetylcholine receptor patients, or patients who are undergoing treatment.
Is Sabine s Coppieters, MD currently recruiting for clinical trials?
Yes, Sabine s Coppieters, MD is currently recruiting for 3 clinical trials in Boca Raton Florida. If you're interested in participating, you should apply.
Are there any treatments that Sabine s Coppieters, MD has studied deeply?
Yes, Sabine s Coppieters, MD has studied treatments such as efgartigimod PH20 SC, Efgartigimod PH20 SC, Placebo.
What is the best way to schedule an appointment with Sabine s Coppieters, MD?
Apply for one of the trials that Sabine s Coppieters, MD is conducting.
What is the office address of Sabine s Coppieters, MD?
The office of Sabine s Coppieters, MD is located at: Investigator site 2 - US0010087, Boca Raton, Florida 33428 United States. This is the address for their practice at the Investigator site 2 - US0010087.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.